Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.07 USD
Change Today +0.0012 / 1.71%
Volume 14.5K
As of 9:57 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

manhattan scientifics inc (MHTX) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/21/14 - $0.18
52 Week Low
04/13/15 - $0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

manhattan scientifics inc (MHTX) Related Businessweek News

No Related Businessweek News Found

manhattan scientifics inc (MHTX) Details

Manhattan Scientifics, Inc., together with its subsidiaries, focuses on the technology transfer and commercialization of disruptive technologies in the nano medicine space in the United States. It is developing commercial medical prosthetics applications for its ultra-fine grain metals; and plans to commercialize the cancer research work and nano medical applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

8 Employees
Last Reported Date: 03/31/15
Founded in 1992

manhattan scientifics inc (MHTX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $150.0K
President of Senior Scientific
Total Annual Compensation: $205.5K
Compensation as of Fiscal Year 2013.

manhattan scientifics inc (MHTX) Key Developments

Manhattan Scientifics Explore Strategic Alternatives

Manhattan Scientifics, Inc. (OTCPK:MHTX) (MSI) announced that it has retained Imperial Capital, LLC to explore strategic alternatives for its Metallicum division. The Chief Executive Officer Manny Tsoupanarias said, "In reacquiring our nano-metals technology from our former licensee we believe we added in excess of $10 million in non-cash assets to our balance sheet, plus $8.0 million in cash. We believe our metals technology is more vital now than ever before. Accordingly we retained the M&A services of Imperial Capital, LLC, an investment bank, to explore strategic alternatives to capitalize on our metals technology as it relates to Metallicum Inc."

Manhattan Scientifics Inc. Appoints Marvin Maslow as Member of the Board of Directors

On March 13, 2015, Marvin Maslow was elected as a member of the Board of Directors of Manhattan Scientifics Inc. Marvin Maslow served as the CEO of the company from January 1998 until November 2007 and served as Chairman Emeritus of the company from 2008 through 2015.

Manhattan Scientific, Inc. Announces Auditor Changes

On January 30, 2015, Manhattan Scientific, Inc. was notified by L.L. Bradford & Company, LLC that the firm has decided to discontinue the performance of public company audit services. Certain clients of Bradford are transitioning to RBSM, LLP, to serve as their independent registered public accounting firm. As Bradford was engaged by the company commencing on June 20, 2014 and did not participate in an audit of the company's financial statements, Bradford has not issued a report and has not expressed an audit opinion on the company's financial statements for any year end. On February 5, 2015, the company engaged RBSM as its independent registered public accounting firm for the company's fiscal year ended December 31, 2014. The decision to engage RBSM as the company's independent registered public accounting firm was approved by the company's Board of Directors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MHTX:US $0.07 USD +0.0012

MHTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MHTX.
View Industry Companies

Industry Analysis


Industry Average

Valuation MHTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 53.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 44.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MANHATTAN SCIENTIFICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at